Follow
Harri Järveläinen
Harri Järveläinen
Biotech Chief Operating Officer
Verified email at jarvelainen.org - Homepage
Title
Cited by
Cited by
Year
Sex difference in alcohol‐related organ injury
N Sato, KO Lindros, E Baraona, K Ikejima, E Mezey, HA Järveläinen, ...
Alcoholism: Clinical and Experimental Research 25, 40S-45S, 2001
2092001
Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease
HA Järveläinen, A Orpana, M Perola, VT Savolainen, PJ Karhunen, ...
Hepatology 33 (5), 1148-1153, 2001
1982001
Effect of Chronic Coadministration of Endotoxin and Ethanol on Rat Liver Pathology and Proinflammatory and Anti–Inflammatory Cytokines
HA Järveläinen, C Fang, M Ingelman-Sundberg, KO Lindros
Hepatology 29 (5), 1503-1510, 1999
1601999
Models of alcoholic liver disease in rodents: a critical evaluation
PM Hall, CS Lieber, LM DeCarli, SW French, KO Lindros, H Järveläinen, ...
Alcoholism: Clinical and Experimental Research 25, 254S-261S, 2001
1082001
Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure
C Fang, S Yoon, N Tindberg, HA Järveläinen, KO Lindros, ...
Biochemical pharmacology 67 (7), 1389-1397, 2004
1022004
Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver
HA Järveläinen, C Fang, M Ingelman-Sundberg, TA Lukkari, H Sippel, ...
Journal of hepatology 32 (6), 900-910, 2000
852000
A new oral low-carbohydrate alcohol liquid diet producing liver lesions: a preliminary account
KAIO LINDROS, HA JÄRVELÄINEN
Alcohol and Alcoholism 33 (4), 347-353, 1998
831998
L-carnitine alleviates alcohol-induced liver damage in rats: role of tumour necrosis factor-alpha
I Bykov, H Järveläinen, K Lindros
Alcohol and alcoholism 38 (5), 400-406, 2003
772003
Alcohol affects the skeletal muscle proteins, titin and nebulin in male and female rats
RJ Hunter, VR Preedy, C Neagoe, HA Järveläinen, CR Martin, KO Lindros, ...
The Journal of nutrition 133 (4), 1154-1157, 2003
762003
Caspase-1 activation by Salmonella
HA Järveläinen, A Galmiche, A Zychlinsky
Trends in cell biology 13 (4), 204-209, 2003
622003
The antiestrogen toremifene protects against alcoholic liver injury in female rats
HA Järveläinen, TA Lukkari, S Heinaro, H Sippel, KO Lindros
Journal of hepatology 35 (1), 46-52, 2001
612001
Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver
TA Lukkari, HA Järveläinen, T Oinonen, E Kettunen, KO Lindros
Alcohol and Alcoholism 34 (3), 311-319, 1999
531999
Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat
HA Järveläinen, A Väkevä, KO Lindros, S Meri
Clinical Immunology 105 (1), 57-63, 2002
522002
Alcohol‐induced expression of the CD14 endotoxin receptor protein in rat Kupffer cells
HA Järveläinen, T Oinonen, KO Lindros
Alcoholism: Clinical and Experimental Research 21 (8), 1547-1551, 1997
521997
Protective function of complement against alcohol-induced rat liver damage
IL Bykov, A Väkevä, HA Järveläinen, S Meri, KO Lindros
International immunopharmacology 4 (12), 1445-1454, 2004
372004
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in …
A Dean, S Gill, M McGregor, V Broadbridge, HA Järveläinen, T Price
The Lancet gastroenterology & hepatology 7 (10), 943-951, 2022
342022
Chronic systemic endotoxin exposure: an animal model in experimental hepatic encephalopathy
KO Lindros, HA Järveläinen
Metabolic brain disease 20, 393-398, 2005
302005
1528P Phase I trial of the first-in-class agent CEND-1 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
A Dean, S Gill, M McGregor, V Broadbridge, HA Jarvelainen, TJ Price
Annals of Oncology 31, S941, 2020
92020
Acinar Distribution of Rat Liver Arylamine N‐Acetyltransferase: Effect of Chronic Ethanol and Endotoxin Exposure
PS Pronko, HA Järveläinen, KO Lindros
Pharmacology & toxicology 90 (3), 150-154, 2002
62002
Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1
HA Järveläinen, C Schmithals, M von Harten, B Kakoschky, TJ Vogl, ...
International Journal of Molecular Sciences 24 (6), 5700, 2023
52023
The system can't perform the operation now. Try again later.
Articles 1–20